SB Med Co., Ltd. (CEO Ko Dae-cheol) announced that it participated in ‘2023 InterCHARM Korea’ held at COEX in Seoul for a total of 3 days from Wednesday, August 30th to Friday, September 1st.
SB Med is a company that specializes in researching and developing medical devices for skin and obesity care. The company explains that it presents a new direction for ‘K-beauty medical devices’ through long-term research and development and convergence between fields. .
At this exhibition, SB Med introduced its wireless hand-held filler injector ‘Medishine’. This product significantly reduces the difficulty of filler procedures that require a uniform injection speed and amount. Depending on the type of drug used, it can be used in continuous injection or fixed-quantity injection mode. This simple mode conversion enables fast, safe, and effective treatment.
In addition, the pain experienced by the recipient (patient) during the procedure can also be reduced, and the effect of minimizing side effects can be expected. As a medical device that improves both doctors’ and patients’ satisfaction with the procedure, SB Med predicted that there will be high demand in the related market.
An SB Med official said, “Depending on its specificity, filler has a very sticky gel-type formulation, which acts as a factor in increasing the operator’s fatigue and difficulty in injecting the correct amount and injection speed.” He added, “On the other hand, our Medishine “Most of these problems can be solved by using , and based on its performance, it is being sold successfully not only domestically but also in France, UAE, Australia, and China,” he emphasized.
Furthermore, SB Med also announced plans to launch a next-generation device that further upgrades the overall performance of Medishine. An official said, “The goal is to complete development by the second half of 2025 and commercialize the second-generation product ‘SD-200’ model,” and added, “Along with the filler and botox markets that are rapidly growing worldwide, the wireless handheld drug injector market is also expected to grow. “It is predicted that our company will lead the related market through our unique technology and know-how,” he said.
Meanwhile, ‘Intercharm Korea’ is a global beauty and cosmetics exhibition, where more than 50 overseas buyers from 3,000 countries visit every year, discover overseas buyers with purchasing power and invite key players in the potential market. has established itself as a business platform for